Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
44.630USD
-0.980-2.15%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.59BMarket Cap
LossP/E TTM
Supernus Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Supernus Pharmaceuticals Inc is 9.21, ranking 28 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -87.35, which is -1768.69% below the recent high of 1457.52 and -80.64% above the recent low of -157.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.